TY - JOUR
T1 - INTRODUCTION
T2 - Evolution of radiation therapy techniques
AU - Sahgal, Arjun
AU - Sheehan, Jason P.
AU - Niranjan, Ajay
AU - Chambless, Lola B.
AU - Ma, Lijun
AU - Trifiletti, Daniel M.
N1 - Publisher Copyright:
© AANS 2022, except where prohibited by US copyright law
PY - 2022
Y1 - 2022
N2 - R adiation technology has undergone dramatic changes over the past 3 decades. The development of dedicated stereotactic radiosurgery (SRS) delivery units led the initial transformation in the ability to deliver high-dose and high-precision radiation to small intracranial targets. The incorporation of multileaf collimators, image guidance, software allowing for intensity-modulated radiotherapy, frameless head immobilization devices, and 6-degrees-of-freedom positional correction has enabled global adoption and access to SRS beyond highly specialized quaternary academic centers. Furthermore, this technical approach and philosophy has transformed radiation oncology with the ability to deliver these treatments extra-cranially to body targets, otherwise known as stereotactic body radiotherapy (SBRT). The application of SBRT to spinal metastases parallels the evolution of SRS for brain metastases, such that conventional palliative radiation is now considered inferior to SBRT for selected patients. In fact, SBRT has revolutionized the management of patients with oligometastases, shifting treatment intent from a purely palliative approach to a potentially curative reality. In this issue of Neurosurgical Focus, we further our understanding of SRS and stereotactic radiotherapy for primary brain tumors and functional conditions, as well as new developments for patients with brain metastases. We also provide an overview of challenges in response assessment for spine SBRT, as well as evidence supporting the role of SBRT in a rare series dedicated to spinal metastases in patients with hepatocellular carcinoma.
AB - R adiation technology has undergone dramatic changes over the past 3 decades. The development of dedicated stereotactic radiosurgery (SRS) delivery units led the initial transformation in the ability to deliver high-dose and high-precision radiation to small intracranial targets. The incorporation of multileaf collimators, image guidance, software allowing for intensity-modulated radiotherapy, frameless head immobilization devices, and 6-degrees-of-freedom positional correction has enabled global adoption and access to SRS beyond highly specialized quaternary academic centers. Furthermore, this technical approach and philosophy has transformed radiation oncology with the ability to deliver these treatments extra-cranially to body targets, otherwise known as stereotactic body radiotherapy (SBRT). The application of SBRT to spinal metastases parallels the evolution of SRS for brain metastases, such that conventional palliative radiation is now considered inferior to SBRT for selected patients. In fact, SBRT has revolutionized the management of patients with oligometastases, shifting treatment intent from a purely palliative approach to a potentially curative reality. In this issue of Neurosurgical Focus, we further our understanding of SRS and stereotactic radiotherapy for primary brain tumors and functional conditions, as well as new developments for patients with brain metastases. We also provide an overview of challenges in response assessment for spine SBRT, as well as evidence supporting the role of SBRT in a rare series dedicated to spinal metastases in patients with hepatocellular carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=85141151553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141151553&partnerID=8YFLogxK
U2 - 10.3171/2022.8.FOCUS22436
DO - 10.3171/2022.8.FOCUS22436
M3 - Article
C2 - 36321287
AN - SCOPUS:85141151553
SN - 1092-0684
VL - 53
JO - Neurosurgical focus
JF - Neurosurgical focus
IS - 5
M1 - E1
ER -